Abbott presents late-breaking clinical data on treating heart rhythm disorders
27 April 2026 - Global healthcare company Abbott (NYSE:ABT) on Saturday announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PF...